Agile Therapeutics (AGRX) Reports Q2 Loss of $0.27/Share
Tweet
Share
E-mailGet Alerts AGRX Hot Sheet
Join SI Premium – FREE
Agile Therapeutics (NASDAQ: AGRX) reported Q2 EPS of ($0.27), versus ($0.29) reported last year.
For earnings history and earnings-related data on Agile Therapeutics (AGRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
